Marisol Gonzalez Counselor Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 095-707-9264 |
Pegi Mueller, BA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-1582 |
Tiffany Deleon, AA Counselor Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-4124 |
Decorah Curren, BS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-1582 |
Kayleen Elizabeth Simpson Counselor Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 860-986-9998 |
Bonnie Russell, BS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-1582 |
Roger Alan Mar, MBA Counselor Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 |
Ms. Karely Garcia Acevedo, B.A SOCIAL SERVICES Counselor Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 |
Frederick Chapman, MSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-1582 |
Brandon Ghoreishi, BA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-4124 |
Rebecca Peterson Counselor Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-4124 |
Katherine Ochoa, BA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-1582 |
Juan Padilla, BA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-1582 |
Alejandra Serrano Castrellon Counselor Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 |
Ignacio Fabian Gonzales, MS Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 1550 S Pioneer Way Ste 165, Moses Lake, WA 98837 Phone: 509-793-9780 Fax: 509-764-3246 |
Jenny Kohl, MS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-4124 |
Aaron Glenn, BA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-1582 |
Cecilia Hernandez Godinez, LMHCA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 |
Bronsen William Smith, MHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-765-9239 Fax: 509-765-4124 |
Carla Guadalupe Lopez Aguilar Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 840 E Plum St, Moses Lake, WA 98837 Phone: 509-764-2011 |
News Archive
Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.
Patients with cardiovascular disease who develop major internal bleeding are much more likely to be diagnosed with cancer, a large international clinical trial has found.
Using genetic information from 569 hospital patients, the researchers showed that their predictive model could estimate an individual's overall risk of cardioembolic stroke - the most common form of stroke - with 86 percent accuracy. The findings are reported in the March issue of Stroke.
Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the third quarter of 2011.
› Verified 5 days ago